To be added to our mailing list, complete the fields below.
The August issue of the Journal of Oncology Practice (JOP) is a Special Series on ASCO’s 2017 Quality Care Symposium (QCS). The issue features research and highlights from this year’s meeting that brought together top leaders in the field to share strategies and methods for measuring and improving the quality and safety of cancer care.
A new article in the Journal of Clinical Oncology (JCO) summarizes the discussions of ASCO’s “Omics and Precision Oncology Workshop,” led by the CancerLinQ Oncology Informatics Task Force (formerly the ASCO Health Information Technology Workgroup), along with the key challenges and recommendations identified by the participants. ASCO held the workshop last October, to begin to address four issues identified at the Data Standards and Interoperability Summit held earlier in the year: omics and precision oncology, advancing interoperability, patient engagement, and value-based oncology.
The Quality Care Symposium’s (QCS) second annual Joseph C. Simone Award and Lecture is highlighted in a new Journal of Oncology Practice (JOP) article. The Award and Lecture honors an extraordinary individual who has made multiple significant contributions to the quality and safety of cancer care.
Draft recommendations as part of a focused update to the ASCO/College of American Pathologists (CAP) evidence-based guideline for human epidermal growth factor receptor 2 (HER2) testing in breast cancer are now open for public comment through June 12, 2017.
ASCO has announced the launch of its Center for Research & Analytics (CENTRA), which aims to make an array of cancer data available to the oncology community and provide consultation and support for research and analysis. To help guide the program, ASCO has appointed Elizabeth Garrett-Mayer, PhD, to serve as ASCO's Director of Biostatistics and Data Management division.
On June 7 at noon (ET), ASCO will host a one-hour webinar for participants to learn more about the Quality Oncology Practice Initiative (QOPI®) Certification Program.
On May 24 at noon (ET), ASCO will host a one-hour webinar for participants to learn more about the Quality Oncology Practice Initiative (QOPI®) Certification Program.
On May 22, CancerLinQ LLC Chief of Strategic Alliances Jennifer L. Wong will be speaking at an event hosted by the MIT Enterprise Forum (MITEF) of New York City titled “Outsmarting Cancer: How New Technologies are Tackling a Cure.”
In April 2017, the American Society of Pediatric Hematology/Oncology (ASPHO) Board of Trustees voted unanimously to formally endorse the newest version of ASCO and the Oncology Nursing Society’s (ONS) joint chemotherapy administration safety standards.
ASCO has joined a coalition of more than a dozen specialty societies in supporting an effort in the U.S. House of Representatives to relieve the significant administrative burdens and financial penalties slated to be imposed on physicians in 2018 as part of the Medicare physician fee schedule (MPFS)—due to be released this summer. ASCO is concerned about the impact these burdens could have on patient care since oncologists would have to juggle the requirements of multiple Medicare quality improvement programs in addition to time spent providing patient care.